Inflammation symptom

Acute clinical mastitis is characterised by a range of visible cardinal inflammation symptoms. These are used in the diagnosis of the disease and can be divided into rubor (redness), tumor (swelling), dolor (pain), calor (warmness) and functio laesa (dysfunction, represented by secretory alterations like flakes, clots and aqueous milk secret). However, not all five symptoms... 

Besides the acute type of mastitis, which is generally accompanied by a more or less decrease in general health condition of the affected cow, less severe types of mastitis expressing only secretion symptoms are more common in dairy practice. These types are called chronic mastitis. An interim type is the so-called sub-acute mastitis with slight inflammation symptoms. The severity levels and symptoms of mastitis are described in Table 11.3. 

Dual inhibitors of COX and 5-LOX will not only suppress prostaglandins that contribute to acute inflammation conditions, but also address the accumulation of phagocytic leukotrienes that are directly associated with chronic inflammation symptoms. With the existence of COX-1 inhibition activities, dual inhibitors will also possess the cardio protective functions. Those characteristics suggest that there may be distinct advantages to dual inhibitors of COX and 5-LOX over selective COX-2 inhibitors and NSAIDs. This concept has been proved to be valid on in vivo models with synthetic drug candidates [105]. 

The predominant clinical use of corticosteroids is a result of their associated antiinflammatory properties. These are commonly used as topicals for the suppression of symptoms, including inflammation, occurring in a particular disease state these compounds are rarely considered curative in their usage. Many other disease states do, however, respond well symptomatically to treatment with corticosteroid therapy. Some of these (11) are Hsted below. 

Mild exposure to HF via inhalation can irritate the nose, throat, and respiratory system. The onset of symptoms may be delayed for several hours. Severe exposure via inhalation can cause nose and throat bums, lung inflammation, and pulmonary edema, and can also result in other systemic effects including hypocalcemia (depletion of body calcium levels), which if not promptly treated can be fatal. Permissible air concentrations are (42) OSHA PEL, 3 ppm (2.0 mg/m ) as E OSHA STEL, 6 ppm (5.2 mg/m ) as E and ACGIH TLV, 3 ppm (2.6 mg/m ) as E. Ingestion can cause severe mouth, throat, and stomach bums, and maybe fatal. Hypocalcemia is possible even if exposure consists of small amounts or dilute solutions of HE. 

These steioids aie capable of preventing or suppressing the development of the sweUing, redness, local heat, and tenderness which characterize inflammation. They inhibit not only the acute symptoms of the inflammatory process, such as edema, fibrin deposition, and capillary dilatation, but also the chronic manifestations. There is evidence that glucocorticoids induce the synthesis of a protein that inhibits phosphoHpase A 2 (60), diminishing the release of arachidonic acid from phosphoHpids (Fig. 2), thereby reducing chemotaxis and inflammation. 

Physiological Effects. The sulfur and nitrogen mustards act first as cell irritants and finally as a cell poison on all tissue surfaces contacted. The first symptoms usually appear in 4—6 h (4). The higher the concentration, the shorter the interval of time between the exposure to the agent and the first symptoms. Local action of the mustards results in conjunctivitis (inflammation of the eyes) erythema (redness of the skin), which may be followed by blistering or ulceration and an inflammatory reaction of the nose, throat, trachea, bronchi, and lung tissue. Injuries produced by mustard heal much more slowly and are much more Fable to infection than bums of similar intensity produced by physical means or by other chemicals. 

Gastroenteritis Gastroenteritis is an acute inflammation of the lining of the stomach and intestines. Symptoms include anorexia, nausea, diarrhea, abdominal pain and weakness. Gastroenteritis has many causes, such as bacteria (food poisoning), viruses, parasites, consumption of irritating food or drink, as well as stress. Treatment for the condition depends on the underlying cause. 

Health Hazards Information - Recommended Personal Protective Equipment Goggles or face shield, rubber gloves Symptoms Following Exposure Inhalation causes headache, nausea, and irritation of nose and throat. Vapor irritates eyes liquid causes inflammation and corneal opacity. Contact of skin with liquid causes dryness and irritation. Ingestion causes headache, nausea, and irritation of mouth and... 

Health Hazards Information - Recommended Personal Protective Equipment Chemical goggles face shield oil-resistant gloves Symptoms Following Exposure Contact with eyes causes mild inflammation. Contact with skin may produce allergic response General Treatment for Exposure EYES or SKIN remove excess oil with cloth or absorbent paper then wash with soapy water and flush with clear water consult a physician Toxicity by Inhalation (Threshold Limit Value) Data not available Short-Term Inhalation Limits Data not available Toxicity by Ingestion Grade 0 LDjj > 15 g/kg Late Toxicity Data not available Vapor (Gas) Irritant Characteristics Data not available Liquid or Solid Irritant Characteristics Data not available Odor Threshold Data not available. 

Allergic alveolitis An allergic response to inhalation of organic particles that involves inflammation of the small terminal branches of the bronchioles. Symptoms include coughing, increased production of mucus, fever, fatigue, and muscle aches. 

Platelet activating factor (PAF) was first identified by its ability (at low levels) to cause platelet aggregation and dilation of blood vessels, but it is now known to be a potent mediator in inflammation, allergic responses, and shock. PAF effects are observed at tissue concentrations as low as 10 M. PAF causes a dramatic inflammation of air passages and induces asthma-like symptoms in laboratory animals. Toxic-shock syndrome occurs when fragments of destroyed bacteria act as toxins and induce the synthesis of PAF. This results in a drop in blood pressure and a reduced... 

The activation of mast cells by allergen initiates the asthma symptoms within minutes after allergen contact, the early allergic response (EAR), within horns the late allergic response (LAR), and within years and after rqDeated asthma episodes, chronic airway inflammation, airway remodeling, and airway hyperresponsiveness. 

Multiple scelerosis is an autoimmune disease mediated by T and B lymphocytes and macrophages. This is characterized by extensive inflammation and demyelination of the myelin sheath that surrounds the nerve fiber. The death of the nerve fiber results in a variety of symptoms that can lead to impairment of movement, paralysis, and death. 

Systemic treatment of 13-cis retinoic acid frequently leads to cheilitis and eye irritations (e.g., unspecific cornea inflammation). Also other symptoms such as headache, pruritus, alopecia, pains of joints and bone, and exostosis formation have been reported. Notably, an increase of very low density lipoproteins and triglycerides accompanied by a decrease of the high density lipoproteins has been reported in 10-20% of treated patients. Transiently, liver function markers can increase during oral retinoid therapy. Etretinate causes the side effects of 13-cis retinoid acid at lower doses. In addition to this, generalized edema and centrilobulary toxic liver cell necrosis have been observed. 

---